AI and Clinical Practice—AI Guardrails: The US Executive Order and the Need for Global Harmonization

Artificial intelligence holds the promise of revolutionizing disease diagnosis and prediction, but it also presents a pivotal challenge: ensuring equity. In this Q&A, Alondra Nelson, PhD, the Harold F. Linder Professor at the Institute for Advanced Study, joins JAMA's Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss the equitable regulation of AI to benefit all populations. Related Content:

• How Do Policymakers Regulate AI and Accommodate Innovation in Research and Medicine?